ACM
AIGH Capital Management Portfolio holdings
AUM
$213M
This Quarter Return
+3.71%
1 Year Return
+95.37%
3 Year Return
+329.16%
5 Year Return
–
10 Year Return
–
AUM
$207M
AUM Growth
+$207M
(-18%)
Cap. Flow
-$89.8M
Cap. Flow
% of AUM
-43.3%
Top 10 Holdings %
Top 10 Hldgs %
50.71%
Holding
54
New
13
Increased
10
Reduced
12
Closed
11
Top Buys
| 1 |
Humacyte
HUMA
|
$6.71M |
| 2 |
Beyond Air
XAIR
|
$6.46M |
| 3 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$6.22M |
| 4 |
Ideal Power
IPWR
|
$5.98M |
| 5 |
OneSpan
OSPN
|
$5.82M |
Top Sells
| 1 |
Adverum Biotechnologies
ADVM
|
$42.6M |
| 2 |
Aspen Aerogels
ASPN
|
$28.5M |
| 3 |
indie Semiconductor
INDI
|
$18.3M |
| 4 |
TGAN
Transphorm, Inc. Common Stock
TGAN
|
$16.9M |
| 5 |
SPRB
Spruce Biosciences, Inc. Common Stock
SPRB
|
$6.22M |
Sector Composition
| 1 | Healthcare | 67.6% |
| 2 | Technology | 20.27% |
| 3 | Industrials | 12.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
SPDR S&P Biotech ETF
XBI
$5.26B
| – | – |
0
| – | – |
|
|
SPRB
52
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| – | – |
-2,123,863
| Closed | -$6.22M |
|
|
TFFP
53
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| – | – |
-29,482
| Closed | -$207K |
|
|
TGAN
54
DELISTED
Transphorm, Inc. Common Stock
TGAN
| – | – |
-4,621,058
| Closed | -$16.9M |
|